Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial von Robertson, John F R, Prof, Bondarenko, Igor M, Prof, Trishkina, Ekaterina, PhD, Dvorkin, Mikhail, MD, Panasci, Lawrence, Prof, Manikhas, Alexey, MD, Shparyk, Yaroslav, PhD, Cardona-Huerta, Servando, PhD, Cheung, Kwok-Leung, MD, Philco-Salas, Manuel Jesus, MD, Ruiz-Borrego, Manuel, MD, Shao, Zhimin, Prof, Noguchi, Shinzaburo, Prof, Rowbottom, Jacqui, MSc, Stuart, Mary, MD, Grinsted, Lynda M, MSc, Fazal, Mehdi, MD, Ellis, Matthew J, Prof

Volltext

Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase von Algire, Carolyn, Amrein, Lilian, Zakikhani, Mahvash, Panasci, Lawrence, Pollak, Michael

Volltext

PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines von Sharif-Askari, Bahram, Amrein, Lilian, Aloyz, Raquel, Panasci, Lawrence

Volltext

Precision spherical nucleic acids for delivery of anticancer drugs von Bousmail, Danny, Amrein, Lilian, Fakhoury, Johans J, Fakih, Hassan H, Hsu, John C C, Panasci, Lawrence, Sleiman, Hanadi F

Volltext

Phase I/II Trial of Sorafenib in Combination with Vinorelbine as First-Line Chemotherapy for Metastatic Breast Cancer von Ferrario, Cristiano, Strepponi, Ivan, Esfahani, Khashayar, Charamis, Helen, Langleben, Adrian, Scarpi, Emanuela, Nanni, Oriana, Miller, Jr, Wilson H, Panasci, Lawrence C

Volltext

The PARP inhibitor ABT-888 synergizes irinotecan treatment of colon cancer cell lines von Davidson, David, Wang, Yunzhe, Aloyz, Raquel, Panasci, Lawrence

Volltext

PARP Inhibition Sensitizes Breast Cancer Cells to Eribulin von Sharif-Askari, Bahram, Panasci, Lawrence, Aloyz, Raquel

Volltext

Sequence-responsive unzipping DNA cubes with tunable cellular uptake profiles von Bujold, Katherine E., Fakhoury, Johans, Edwardson, Thomas G. W., Carneiro, Karina M. M., Briard, Joel Neves, Godin, Antoine G., Amrein, Lilian, Hamblin, Graham D., Panasci, Lawrence C., Wiseman, Paul W., Sleiman, Hanadi F.

Volltext

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases von Lazaratos, Anna-Maria, Maritan, Sarah M., Quaiattini, Andrea, Darlix, Amelie, Ratosa, Ivica, Ferraro, Emanuela, Griguolo, Gaia, Guarneri, Valentina, Pellerino, Alessia, Hofer, Silvia, Jacot, William, Stemmler, Hans-Joachim, van den Broek, Marcel P.H., Dobnikar, Nika, Panet, Francois, Lahijanian, Zubin, Morikawa, Aki, Seidman, Andrew D., Soffietti, Riccardo, Panasci, Lawrence, Petrecca, Kevin, Rose, April A.N., Bouganim, Nathaniel, Dankner, Matthew

Volltext

Different impact of excision repair cross-complementing group 1 on survival von Panasci, Lawrence C

Volltext

Pegylated Liposomal Doxorubicin and Trastuzumab in HER-2 Overexpressing Metastatic Breast Cancer: A Multicenter Phase II Trial von CHIA, Stephen, CLEMONS, Mark, MARTIN, Lee-Ann, RODGERS, Angela, GELMON, Karen, POND, Gregory R, PANASCI, Lawrence

Volltext

Are frailty markers useful for predicting treatment toxicity and mortality in older newly diagnosed cancer patients? Results from a prospective pilot study von Puts, Martine T.E, Monette, Johanne, Girre, Veronique, Pepe, Carmela, Monette, Michele, Assouline, Sarit, Panasci, Lawrence, Basik, Mark, Miller, Wilson H, Batist, Gerald, Wolfson, Christina, Bergman, Howard

Volltext

The risks associated with the widespread use of telemedicine in oncology: Four cases and review of the literature von Panet, François, Tétreault‐Langlois, Marianne, Morin, Vincent, Sultanem, Khalil, Melnychuk, David, Panasci, Lawrence

Volltext

Xenografts of Human Hepatocellular Carcinoma: A Useful Model for Testing Drugs von HUYNH, Hung, KHEE CHEE SOO, CHOW, Pierce K. H, PANASCI, Lawrence, TRAN, Evelyn

Volltext

Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer von McLean, James, Rho, Young Soo, Kuruba, Gayathri, Mamo, Aline, Gilabert, Marine, Kavan, Tomas, Panasci, Lawrence, Melnychuk, David, Batist, Gerald, Kavan, Petr

Volltext

Phase II Multicenter Trial of Anthracycline Rechallenge With Pegylated Liposomal Doxorubicin Plus Cyclophosphamide for First-Line Therapy of Metastatic Breast Cancer Previously Tre... von Trudeau, Maureen E, Clemons, Mark J, Provencher, Louise, Panasci, Lawrence, Yelle, Louise, Rayson, Daniel, Latreille, Jean, Vandenberg, Ted, Goel, Rakesh, Zibdawi, Labib, Rahim, Yasmin, Pouliot, Jean-Francois

Volltext

Abstract 300: A new combination therapy to treat metastatic breast cancer von Sharif-Askari, Bahram, Aloyz, Raquel, Panasci, Lawrence

Volltext

Docetaxel plus cyclophosphamide in adjuvant breast cancer von Ferrario, Cristiano, Panasci, Lawrence C

Volltext

Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer von Panasci, Lawrence C

Volltext

Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer : Cancer and leukemia Group B study 8662 von HAYES, Daniel F, YAMAUCHI, Hideko, NORTON, Larry, HENDERSON, I. Craig, BROADWATER, Gloria, CIRRINCIONE, Constance T, RODRIGUE, Stephen P, BERRY, Donald A, YOUNGER, Jerry, PANASCI, Lawrence L, MILLARD, Frederick, DUGGAN, David B

Volltext